Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
98 EUR | -1.01% | -.--% | +2.08% |
03/06 | Eli Lilly: encouraging data for olomorasib | CF |
03/06 | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- Revisions Eli Lilly and Company